norse: erdafitinib and cetrelimab in urothelial carcinoma
Published 1 year ago • 96 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
3:42
norse: erdafitinib cetrelimab in muc with fgfr alterations
-
1:47
the future role of erdafitinib in advanced urothelial carcinoma
-
2:20
erdafitinib /- cetrelimab in muc patients with fgfr alterations
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
2:31
an update on erdafitinib for metastatic/uresectable fgfr alteration urothelial carcinoma
-
2:47
#esmo21 highlights on erdafitinib in adv. urothelial cancer with fgfra alterations: the norse study
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
6:09
erdafitinib (erda) or erda plus cetrelimab for patients with metastatic or locally advanced urot...
-
1:22
key clinical trials in urothelial carcinoma at esmo 2021
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
1:28
erdafitinib for bladder cancer: more to come following fda approval
-
2:12
erdafitinib: one more tool for bladder cancer
-
2:23
promising early results for cetrelimab plus erdafitinib reported for advanced uc | thomas powles
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
0:55
targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
-
2:15
tar-210 erdafitinib intravesical delivery system in non-muscle invasive bladder cancer
-
3:26
blc2001: erdafitinib for muc
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma